Engum Anne, Bjøro Trine, Mykletun Arnstein, Dahl Alv A
Department of Psychiatry, Nord-Trøndelag Hospital Trust, Hospital Levanger, Norway.
J Psychosom Res. 2005 Nov;59(5):263-8. doi: 10.1016/j.jpsychores.2005.04.002.
The aim of the study was to examine the relationship between antithyroid antibodies, depression, and anxiety in a large population.
In a population of 30,175 individuals aged 40-84 years, thyroid-stimulating hormone (TSH) was assessed in all women and in 50% of the men. Thyroid peroxidase autoantibodies (TPOAb) were measured in almost all samples with TSH > or = 4.0 mU/L (n = 1700) and in randomly selected samples without thyroid disease or biochemical dysfunction (n = 745). The levels of anxiety and depression were screened using the Hospital Anxiety and Depression Scale (HADS). Relations were investigated with multiple logistic regression analyses.
In individuals with normal TSH and without known thyroid disorder, the prevalence of TPOAb was 14.2% in women and 4.3% in men. The prevalence of TPOAb in participants with biochemical thyroid dysfunction was 59.0% in women and 38.9% in men. No associations were found between thyroid autoimmunity and depression or anxiety, neither crude nor adjusted for age, gender, TSH, and thyroxine (T4).
Thyroid autoimmunity is a common disorder in the population, mainly affecting females. In a population-based study, no associations were found between antithyroid antibodies and depression or anxiety.
本研究旨在探讨一大群人中抗甲状腺抗体与抑郁和焦虑之间的关系。
在30175名年龄在40 - 84岁的人群中,对所有女性和50%的男性进行促甲状腺激素(TSH)评估。对几乎所有TSH≥4.0 mU/L的样本(n = 1700)以及随机选取的无甲状腺疾病或生化功能障碍的样本(n = 745)检测甲状腺过氧化物酶自身抗体(TPOAb)。使用医院焦虑抑郁量表(HADS)筛查焦虑和抑郁水平。通过多元逻辑回归分析研究相关性。
在TSH正常且无已知甲状腺疾病的个体中,女性TPOAb患病率为14.2%,男性为4.3%。甲状腺生化功能障碍参与者中女性TPOAb患病率为59.0%,男性为38.9%。未发现甲状腺自身免疫与抑郁或焦虑之间存在关联,无论是未经调整还是在调整年龄、性别、TSH和甲状腺素(T4)后。
甲状腺自身免疫在人群中是一种常见疾病,主要影响女性。在一项基于人群的研究中,未发现抗甲状腺抗体与抑郁或焦虑之间存在关联。